- Stocks
- Technology
- NASDAQ: MLAB

Price (delayed)

$140.7

Market cap

$752.21M

P/E Ratio

N/A

Dividend/share

$0.64

EPS

-$0.28

Enterprise value

$915.15M

Mesa Labs is a global leader in the design and manufacturing of critical quality control solutions for the pharmaceutical, healthcare, medical device, industrial safety, environmental, and food and beverage industries.

The gross profit has grown by 37% YoY and by 3.1% from the previous quarter

MLAB's revenue is up by 36% year-on-year

Mesa Laboratories's net income has shrunk by 119% YoY but it has surged by 63% QoQ

The company's EPS has shrunk by 119% YoY but it has surged by 63% QoQ

The company's quick ratio fell by 13% YoY and by 8% QoQ

What are the main financial stats of MLAB

Market
Valuations
Earnings

Shares outstanding

5.35M

Market cap

$752.21M

Enterprise value

$915.15M

Price to earnings (P/E)

N/A

Price to book (P/B)

1.94

Price to sales (P/S)

3.38

EV/EBIT

204.73

EV/EBITDA

23.7

EV/Sales

4.12

Revenue

$222.37M

EBIT

$4.47M

EBITDA

$38.62M

Free cash flow

$20.47M

Per share
Balance sheet
Liquidity

EPS

-$0.28

Free cash flow per share

$3.83

Book value per share

$72.55

Revenue per share

$41.65

TBVPS

$28.79

Total assets

$662.98M

Total liabilities

$275.78M

Debt

$189.04M

Equity

$387.21M

Working capital

$72.57M

Debt to equity

0.49

Current ratio

2.74

Quick ratio

1.65

Net debt/EBITDA

4.22

Margins
Efficiency
Dividend

EBITDA margin

17.4%

Gross margin

61%

Net margin

-0.7%

Operating margin

1.2%

Return on assets

-0.2%

Return on equity

-0.4%

Return on invested capital

1.6%

Return on capital employed

0.7%

Return on sales

2%

Dividend yield

0.45%

DPS

$0.64

Payout ratio

N/A

How has the Mesa Laboratories stock price performed over time

Intraday

-0.26%

1 week

-11.34%

1 month

-12.6%

1 year

-33.24%

YTD

-15.35%

QTD

-19.48%

How have Mesa Laboratories's revenue and profit performed over time

Revenue

$222.37M

Gross profit

$135.6M

Operating income

$2.69M

Net income

-$1.47M

Gross margin

61%

Net margin

-0.7%

The operating margin has soared by 186% from the previous quarter but it has plunged by 79% YoY

MLAB's operating income has soared by 184% from the previous quarter but it has plunged by 70% YoY

Mesa Laboratories's net income has shrunk by 119% YoY but it has surged by 63% QoQ

The net margin has plunged by 115% YoY but it has soared by 61% from the previous quarter

What is Mesa Laboratories's growth rate over time

What is Mesa Laboratories stock price valuation

P/E

N/A

P/B

1.94

P/S

3.38

EV/EBIT

204.73

EV/EBITDA

23.7

EV/Sales

4.12

The company's EPS has shrunk by 119% YoY but it has surged by 63% QoQ

MLAB's price to book (P/B) is 57% less than its 5-year quarterly average of 4.5 and 25% less than its last 4 quarters average of 2.6

MLAB's equity is up by 3.5% since the previous quarter but it is down by 2.3% year-on-year

The P/S is 59% below the 5-year quarterly average of 8.3 and 32% below the last 4 quarters average of 5.0

MLAB's revenue is up by 36% year-on-year

How efficient is Mesa Laboratories business performance

MLAB's return on equity has dropped by 121% year-on-year but it has surged by 60% since the previous quarter

The return on assets has dropped by 117% year-on-year but it has surged by 67% since the previous quarter

The company's return on sales has shrunk by 76% YoY

Mesa Laboratories's return on invested capital has shrunk by 74% YoY

What is MLAB's dividend history

DPS

$0.64

Dividend yield

0.45%

Payout ratio

N/A

Recent dividends

How did Mesa Laboratories financials performed over time

Mesa Laboratories's total assets is 140% more than its total liabilities

The total liabilities has contracted by 15% YoY and by 2.2% from the previous quarter

The company's quick ratio fell by 13% YoY and by 8% QoQ

The debt is 51% less than the equity

The debt has contracted by 17% YoY and by 3.9% from the previous quarter

MLAB's debt to equity is down by 16% YoY and by 8% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.